HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial. - Wikidata - awgldk - TriplyDB

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.

http://www.wikidata.org/entity/Q51751068

about

Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Characterization of DNA Methylation in Circulating Tumor Cells Single-cell analyses of circulating tumor cells Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials Minimal residual disease and circulating tumor cells in breast cancer The promise of circulating tumor cell analysis in cancer management Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection.Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack Potential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current Evidence Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines 'Omic approaches to preventing or managing metastatic breast cancer Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis.Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets.International study on inter-reader variability for circulating tumor cells in breast cancer The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial.Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?Single-Cell Analysis of Circulating Tumor Cells as a Window into Tumor Heterogeneity Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.Circulating tumor cells in non-metastatic triple-negative breast cancer.Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients.Molecular profiling of single circulating tumor cells with diagnostic intention.Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker.Detection of HER2 amplification in circulating free DNA in patients with breast cancer.May CTC technologies promote better cancer management?Gene signatures of breast cancer progression and metastasis.Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity Breast Cancer Update 2014 - Focus on the Patient and the Tumour.Prognostic Relevance of Circulating Tumor Cells in Molecular Subtypes of Breast Cancer.A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.A novel platform for detection of CK+ and CK- CTCs.The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients.Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients.Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients.

P2860

Q21284707-64790804-08C8-47FD-8643-28D1D17B6ED7 Q26748850-C312838C-683B-4E8B-9080-AF28070328F6 Q26778427-CAE47A90-DFBA-464D-BAF8-39E6EF12E76C Q26778816-A4A62519-3F35-40E6-9506-41BDE008A935 Q26827936-A3C722C3-A0D4-4B63-9880-ADE664E83F81 Q27010152-4E122110-90F0-46A1-8BA3-86873AF0C3D8 Q27022113-CDE661B4-4A25-4439-ACB0-531A97A58940 Q27024191-5AF32C35-4067-432A-AE9F-C697B87990DF Q27320919-5768501A-0DD2-4518-95A9-A9A5B52711EC Q28067549-D2C694EB-FA43-4EF7-BBF0-8C7EF48752A0 Q28075850-C229881F-B262-43EE-8436-9224254253A5 Q28483475-1DCF629E-50DD-4AE9-BA3E-C57393CBDE57 Q28730572-EE5572EE-0938-461E-9961-FA7D1AC0A160 Q33559128-E805B6DF-26E6-4322-9492-D5C90A144539 Q33597032-2E9C72F1-DDE1-472E-87C9-FF8E19FE4779 Q33738688-97BF183B-7626-4942-9908-433902E400E9 Q33769034-760AC7B8-00E8-4BE4-B6BA-57155A08EC00 Q33820233-24CA8B2B-F2DE-487F-B5B6-DC3847DF0BA7 Q33883227-A7BA5759-5D85-4E4A-BB65-A769F7274FF1 Q33917455-0A185178-8144-4ACE-BD55-2AFA65261938 Q33958981-28781CDF-60CE-47CD-8AB1-4415A7B09C95 Q34111867-14057FB4-2755-4F84-A0DE-BC6C7B685BB9 Q34485182-4EEFCD87-6422-47F0-A0ED-3BC0B4C5DB8B Q34542660-A89AA1F5-FC59-4A5E-AD04-99FDD3847862 Q34687153-620473CB-4466-4236-80EB-FC7E8AC9183C Q34806810-9B27B4D6-9BD1-4BA8-BDA3-9E4D02C91BAA Q35016353-B170CAA0-53AE-438B-9473-02DFE0B215B3 Q35029477-2E6B8FF4-7D70-4269-B280-E13FD0A491EC Q35053624-05DF4FCD-B83E-4E05-859D-F0A028DBF653 Q35054455-925365E5-E163-4754-B1D8-CEC7173BEB78 Q35124176-1D86438C-7849-4692-8446-8E604ADAB890 Q35180940-2AD880DB-D134-4BB5-83A5-38A3C0C518D1 Q35427994-6DED310A-8F0A-4D85-96D2-2E60E4433762 Q35538013-9DAD5178-9F31-46D5-9F53-AC5BF042A77B Q35558126-9BE4B7FF-5299-47BF-B06F-E37528153EE6 Q35608684-CE896783-BA0F-4FBC-9A98-91E9F1B993D5 Q35612329-A9C10204-CB14-4C3B-9FE1-679267861AD1 Q35619770-526D513B-463C-4D35-A265-E697B7D832C6 Q35735913-8F9CBEE5-CBFC-4A1E-9F0E-D0B6C2B9DB2A Q35749122-81EE78AE-7C17-49AB-820A-09CFDE80A900

P2860

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.

http://www.wikidata.org/entity/Q51751068

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

HER2 status of circulating tum ...... rospective, multicenter trial.

@en

HER2 status of circulating tum ...... rospective, multicenter trial.

@nl

type

label

HER2 status of circulating tum ...... rospective, multicenter trial.

@en

HER2 status of circulating tum ...... rospective, multicenter trial.

@nl

prefLabel

HER2 status of circulating tum ...... rospective, multicenter trial.

@en

HER2 status of circulating tum ...... rospective, multicenter trial.

@nl

P1433

Q51751068-A8F8A6CE-E801-4FD9-89E4-8DFE21A3372C

P1476

Q51751068-04DBB9B4-0075-48A5-8A8A-75DE6EA7D64A

P2093

Q51751068-1324B00C-52AC-4B5B-9A5A-1E1B2A423184

Q51751068-264661BC-4B96-478E-B972-46446A92FB47

Q51751068-4889766D-E2D8-4A8D-BBBE-DFBEF8C77FD0

Q51751068-582A7992-5C62-48DA-B855-BDBE79E9A953

Q51751068-633C927D-DE91-4D55-806B-B24E548FE4A4

Q51751068-7B2DD19C-1886-479E-9AD9-67183DF83CFC

Q51751068-83B98A8F-71D9-45EE-A170-3AA95033B0E3

Q51751068-843849EC-3F28-4582-A744-10F7D95DD903

Q51751068-A3276D13-A5A3-443F-A446-A902E14EAF7F

Q51751068-B9222967-098A-4899-9CAF-39DF326F40D1

P2860

Q51751068-367F1CC4-545C-4E73-9F8A-A699E43FCB62

P2888

Q51751068-92652612-7698-447B-BF92-B793D2B02396

P304

Q51751068-C66AE6E5-484D-4E36-AC7E-1D784E9956C2

P31

Q51751068-A3AE06D9-695B-4201-A2E4-A0F8B2491B21

P356

Q51751068-46FC19E7-08AC-4045-973E-9F1CE0D22C7B

P407

Q51751068-88E747D0-E90A-4A4C-A963-4202088FA36A

P433

Q51751068-22E4D464-CE96-463A-A544-7F58BF846D01

P478

Q51751068-1E668212-7658-409B-85D2-60CCFC0EE838

P50

Q51751068-406A7305-9B5B-4398-A038-3C4EE294EB6E

Q51751068-EAF738BB-E3CD-4CAE-AC87-24665FD38A7F

P577

Q51751068-5D7CC04E-F7F4-4C67-B2D0-BFA97764BF2C

P5875

Q51751068-AE6D71E8-C961-4C51-919C-1B1236274F5A

P698

Q51751068-16DE73FA-7DEF-4D73-9AE3-9B4020E0D9C1

P356

S10549-010-1163-X

P1433

Breast Cancer Research and Treatment

P1476

HER2 status of circulating tum ...... rospective, multicenter trial.

@en

P2093

Brigitte Rack

http://www.w3.org/2001/XMLSchema#string

Christian R Löhberg

http://www.w3.org/2001/XMLSchema#string

Christian Schindlbeck

http://www.w3.org/2001/XMLSchema#string

Christoph Klein

http://www.w3.org/2001/XMLSchema#string

Claus Lattrich

http://www.w3.org/2001/XMLSchema#string

Diethelm Wallwiener

http://www.w3.org/2001/XMLSchema#string

Elmar Stickeler

http://www.w3.org/2001/XMLSchema#string

Erich Solomayer

http://www.w3.org/2001/XMLSchema#string

Kerstin Brocker

http://www.w3.org/2001/XMLSchema#string

Klaus Pantel

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

P2888

s10549-010-1163-x

P304

403-412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-010-1163-X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Andreas Schneeweiss

P577

2010-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46394059

http://www.w3.org/2001/XMLSchema#string

P698

20859679

http://www.w3.org/2001/XMLSchema#string